Just on PUR1900.... according to recent Investment Research --- $3.5Billion Market Potential...
PULM's Share: $3.5Billion Revenue x 50% Share = $1.75Bill $1.75Billion Revenue x 30% EBITDA Margin = ~$650Million EBITDA $650Million EBITDA x 10x multiple = $6.5Billion Dollar Valuation $6.5Billion Dollar Valuation / 40million shares = $162.5 worth of shareholder value...
ISPERSE was DARPA Research project before it's now path to commercialization.
CIPLA (one of India's largest pharma companies, 50% revenue share partner on PUR1900 -- leading candidate) very involved here. List as #1 opportunity for their company.
All comments are solely my opinion. Please formulate your own opinion and act on your own accord on all actions you take.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.